Icotrokinra for treating moderate to severe plaque psoriasis in people 12 years and over [ID6579]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Psoriasis: assessment and management (CG153)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Zasocitinib for treating moderate to severe plaque psoriasis [ID6700]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Topical tapinarof for treating mild to severe plaque psoriasis [ID6712]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC